| Item Type | Name |
|
Academic Article
|
Chronotropic incompetence: a common and progressive finding in pacemaker patients.
|
|
Academic Article
|
Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy.
|
|
Academic Article
|
Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure.
|
|
Academic Article
|
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
|
|
Academic Article
|
Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
|
|
Academic Article
|
Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure.
|
|
Academic Article
|
Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
|
|
Academic Article
|
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
|
|
Academic Article
|
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
|
|
Academic Article
|
Irbesartan in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.
|
|
Academic Article
|
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
|
|
Academic Article
|
Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
|
|
Academic Article
|
Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.
|
|
Academic Article
|
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
|
|
Academic Article
|
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
|
|
Academic Article
|
Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling.
|
|
Academic Article
|
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
|
|
Academic Article
|
Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance.
|
|
Academic Article
|
Aortic valve resistance as an adjunct to the Gorlin formula in assessing the severity of aortic stenosis in symptomatic patients.
|
|
Academic Article
|
Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure.
|
|
Academic Article
|
The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.
|
|
Academic Article
|
Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study.
|
|
Academic Article
|
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
|
|
Academic Article
|
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
|
|
Academic Article
|
Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.
|
|
Academic Article
|
Distribution of left ventricular ejection fraction in patients with ischemic and hypertensive heart disease and chronic heart failure.
|
|
Academic Article
|
Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
|
|
Academic Article
|
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
|
|
Academic Article
|
Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial.
|
|
Academic Article
|
Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.
|
|
Academic Article
|
Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.
|
|
Academic Article
|
Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: overestimation of fiber velocities by conventional midwall measurements.
|
|
Concept
|
Patients
|
|
Academic Article
|
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.
|
|
Academic Article
|
Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.
|
|
Academic Article
|
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
|
|
Academic Article
|
Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).
|
|
Academic Article
|
Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
|
|
Academic Article
|
Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.
|
|
Academic Article
|
Reply: does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF?
|
|
Academic Article
|
History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
|
|
Academic Article
|
Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
|
|
Academic Article
|
Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).
|
|
Academic Article
|
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.
|
|
Academic Article
|
Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
|
|
Academic Article
|
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.
|
|
Academic Article
|
Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
|
|
Academic Article
|
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.
|
|
Academic Article
|
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
|
|
Academic Article
|
Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial.
|
|
Academic Article
|
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
|
|
Academic Article
|
The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.
|
|
Academic Article
|
Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
|
|
Academic Article
|
Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.
|
|
Academic Article
|
Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction.
|
|
Academic Article
|
Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial).
|
|
Academic Article
|
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
|
|
Academic Article
|
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
|
|
Academic Article
|
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
|
|
Academic Article
|
Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor: Relationship to Mortality in Patients With Chronic Heart Failure.
|
|
Academic Article
|
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
|
|
Academic Article
|
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.
|
|
Academic Article
|
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
|
|
Academic Article
|
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
|
|
Academic Article
|
Heart Rate and Outcomes in Hospitalized?Patients With Heart Failure With Preserved Ejection?Fraction.
|
|
Academic Article
|
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
|
|
Academic Article
|
Type of Atrial Fibrillation and Outcomes in?Patients With Heart Failure and Reduced?Ejection?Fraction.
|
|
Academic Article
|
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
|
|
Academic Article
|
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure).
|
|
Academic Article
|
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
|
|
Academic Article
|
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial.
|
|
Academic Article
|
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
|
|
Academic Article
|
Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).
|
|
Academic Article
|
Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
|
|
Academic Article
|
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
|
|
Academic Article
|
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
|
|
Academic Article
|
Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
|
|
Academic Article
|
Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.
|
|
Academic Article
|
Remote Monitoring of Patients With Heart Failure: A White Paper From the Heart Failure Society of America Scientific Statements Committee.
|
|
Academic Article
|
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.
|
|
Academic Article
|
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
|
|
Academic Article
|
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
|
|
Academic Article
|
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
|
|
Academic Article
|
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients?With HFrEF.
|
|
Academic Article
|
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
|
|
Academic Article
|
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
|
|
Academic Article
|
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
|
|
Academic Article
|
Age-Related Characteristics and Outcomes of Patients With Heart?Failure With Preserved Ejection Fraction.
|
|
Academic Article
|
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
|
|
Academic Article
|
Echocardiographic Features of Patients?With Heart?Failure and Preserved?Left Ventricular Ejection Fraction.
|
|
Academic Article
|
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
|
|
Academic Article
|
Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation.
|
|
Academic Article
|
Acute Hemodynamic Effects of Cardiac Resynchronization Therapy Versus Alternative Pacing Strategies in Patients With Left Ventricular Assist Devices.
|
|
Academic Article
|
Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF).
|
|
Academic Article
|
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
|
|
Academic Article
|
Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.
|
|
Academic Article
|
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
|
|
Academic Article
|
Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
|
|
Academic Article
|
Baroreflex Activation Therapy in Patients With Heart?Failure With Reduced Ejection Fraction.
|
|
Academic Article
|
Loop Diuretic Prescription and 30-Day?Outcomes in Older Patients With?Heart?Failure.
|
|
Academic Article
|
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.
|
|
Academic Article
|
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
|
|
Academic Article
|
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
|
|
Academic Article
|
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
|
|
Academic Article
|
Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction.
|
|
Academic Article
|
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
|
|
Academic Article
|
INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction.
|
|
Academic Article
|
Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization.
|
|
Academic Article
|
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction.
|
|
Academic Article
|
Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.
|
|
Academic Article
|
Incidence and Outcomes of Pneumonia in Patients With Heart?Failure.
|
|
Academic Article
|
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE.
|
|
Academic Article
|
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF.
|
|
Academic Article
|
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.
|
|
Academic Article
|
Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF.
|
|
Academic Article
|
Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.
|
|
Academic Article
|
Ensemble machine learning model identifies patients with HFpEF from matrix-related plasma biomarkers.
|
|
Academic Article
|
Baroreflex activation therapy with the Barostim? device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
|
|
Academic Article
|
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.
|
|
Academic Article
|
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
|
|
Academic Article
|
Temporal Characteristics of Device-Based Individual and Integrated?Risk Metrics in Patients With?Chronic?Heart?Failure.
|
|
Academic Article
|
Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients with Heart Failure.
|